BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37772453)

  • 1. The association of sickle cell disorder with adverse outcomes in COVID-19 patients: A meta-analysis.
    Liang T; Guo K; Ni P; Duan G; Zhang R
    J Med Virol; 2023 Oct; 95(10):e29120. PubMed ID: 37772453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 outcomes in patients with sickle cell disease and sickle cell trait compared with individuals without sickle cell disease or trait: a systematic review and meta-analysis.
    Michelon I; Vilbert M; Pinheiro IS; Costa IL; Lorea CF; Castonguay M; Tran TH; Forté S
    EClinicalMedicine; 2023 Dec; 66():102330. PubMed ID: 38162948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis.
    Noubiap JJ; Temgoua MN; Tankeu R; Tochie JN; Wonkam A; Bigna JJ
    Thromb J; 2018; 16():27. PubMed ID: 30305805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors associated with COVID-19 related severity in sickle cell disease.
    Yurtsever N; Nandi V; Ziemba Y; Shi PA
    Blood Cells Mol Dis; 2021 Dec; 92():102627. PubMed ID: 34823201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in outcome of invasive mechanical ventilation between different countries for patients with severe COVID-19: A systematic review and meta-analysis.
    Elsayed HH; Hassaballa AS; Ahmed TA; Gumaa M; Sharkawy HY; Moharram AA
    PLoS One; 2021; 16(6):e0252760. PubMed ID: 34086779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.
    Hoogenboom WS; Alamuri TT; McMahon DM; Balanchivadze N; Dabak V; Mitchell WB; Morrone KB; Manwani D; Duong TQ
    Blood Rev; 2022 May; 53():100911. PubMed ID: 34838342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell disease and coronavirus disease-2019 (COVID-19) infection: a single-center experience.
    Devarashetty SP; Grewal US; Le Blanc K; Walton J; Jones T; Shi R; Master SR; Mansour RP; Ramadas P
    Postgrad Med J; 2023 Aug; 99(1175):1008-1012. PubMed ID: 37399057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals.
    Singh A; Brandow AM; Panepinto JA
    Blood Adv; 2021 Apr; 5(7):1915-1921. PubMed ID: 33792626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated interleukin-6 and adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates.
    Zhang P; Shi L; Xu J; Wang Y; Yang H
    Immunogenetics; 2020 Oct; 72(8):431-437. PubMed ID: 33067641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis.
    Boafor TK; Olayemi E; Galadanci N; Hayfron-Benjamin C; Dei-Adomakoh Y; Segbefia C; Kassim AA; Aliyu MH; Galadanci H; Tuuli MG; Rodeghier M; DeBaun MR; Oppong SA
    BJOG; 2016 Apr; 123(5):691-8. PubMed ID: 26667608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.
    Vai B; Mazza MG; Delli Colli C; Foiselle M; Allen B; Benedetti F; Borsini A; Casanova Dias M; Tamouza R; Leboyer M; Benros ME; Branchi I; Fusar-Poli P; De Picker LJ
    Lancet Psychiatry; 2021 Sep; 8(9):797-812. PubMed ID: 34274033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
    Balanchivadze N; Kudirka AA; Askar S; Almadhoun K; Kuriakose P; Fadel R; Dabak V
    Hemoglobin; 2020 Jul; 44(4):284-289. PubMed ID: 32722950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Fatality Rate and Severity of COVID-19 among Patients with Sickle Cell Disease: A Systematic Review and Meta-Analysis.
    Silva Borborema T; Moreira Brito JC; Lima Batista EM; Siqueira Batista R
    Hemoglobin; 2023 Nov; 47(2):85-96. PubMed ID: 37325879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide retrospective study of critically ill adults with sickle cell disease in France.
    Agbakou M; Mekontso-Dessap A; Pere M; Voiriot G; Picard M; Bourenne J; Ehrmann S; Canet E; Boyer A; Nseir S; Tamion F; Thille AW; Argaud L; Pontis E; Quenot JP; Schneider F; Hot A; Capellier G; Aubron C; Razazi K; Masseau A; Brule N; Reignier J; Lascarrou JB
    Sci Rep; 2021 Nov; 11(1):23132. PubMed ID: 34848756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of COVID-19 hospitalizations in patients with sickle cell disease: A nationwide analysis.
    Ilerhunmwuwa NP; Inyang L; Hakobyan N; Wasifuddin M; Tahir M; Aiwuyo H; Ankah P; Torere BE; Amaechi UM; Wang JC
    Eur J Haematol; 2023 Sep; 111(3):432-440. PubMed ID: 37290934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant association between anemia and higher risk for COVID-19 mortality: A meta-analysis of adjusted effect estimates.
    Wang Y; Nan L; Hu M; Zhang R; Hao Y; Wang Y; Yang H
    Am J Emerg Med; 2022 Aug; 58():281-285. PubMed ID: 35753290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.
    Khan MU; Mushtaq K; Alsoub DH; Iqbal P; Ata F; Chaudhry HS; Iqbal F; Balaraju G; Maslamani MAA; Varughese B; Singh R; Ejji KA; Kaabi SA; Kamel YM; Butt AA
    World J Gastroenterol; 2021 Dec; 27(46):7995-8009. PubMed ID: 35046626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.